James Walter Luccarelli, D.Phil., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electroconvulsive Therapy | 26 | 2023 | 477 | 13.780 |
Why?
|
Catatonia | 6 | 2023 | 158 | 3.160 |
Why?
|
Restraint, Physical | 2 | 2023 | 193 | 1.620 |
Why?
|
Inpatients | 9 | 2023 | 2518 | 1.290 |
Why?
|
Seizures | 5 | 2021 | 2859 | 1.100 |
Why?
|
Borderline Personality Disorder | 2 | 2022 | 736 | 1.000 |
Why?
|
Depressive Disorder, Major | 5 | 2023 | 4644 | 0.970 |
Why?
|
Salpingectomy | 1 | 2023 | 53 | 0.900 |
Why?
|
Demography | 3 | 2023 | 1656 | 0.840 |
Why?
|
Prader-Willi Syndrome | 1 | 2022 | 79 | 0.810 |
Why?
|
Nursing Staff, Hospital | 1 | 2023 | 346 | 0.720 |
Why?
|
Butyrylcholinesterase | 1 | 2019 | 22 | 0.720 |
Why?
|
Acetylene | 1 | 2019 | 7 | 0.690 |
Why?
|
Suicidal Ideation | 3 | 2023 | 1248 | 0.670 |
Why?
|
Hyperparathyroidism | 1 | 2019 | 339 | 0.620 |
Why?
|
Arm Injuries | 1 | 2019 | 160 | 0.620 |
Why?
|
Treatment Outcome | 13 | 2023 | 63114 | 0.610 |
Why?
|
Aerosols | 1 | 2020 | 625 | 0.610 |
Why?
|
Psychotic Disorders | 2 | 2023 | 3046 | 0.600 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2020 | 367 | 0.590 |
Why?
|
Brain Diseases | 2 | 2022 | 1563 | 0.550 |
Why?
|
Anesthetics | 1 | 2021 | 539 | 0.520 |
Why?
|
Self Report | 5 | 2023 | 3558 | 0.490 |
Why?
|
Retrospective Studies | 19 | 2023 | 77449 | 0.490 |
Why?
|
Clinical Protocols | 1 | 2020 | 1462 | 0.480 |
Why?
|
Cognition | 5 | 2022 | 6770 | 0.470 |
Why?
|
Bipolar Disorder | 2 | 2021 | 5027 | 0.470 |
Why?
|
Delirium | 2 | 2022 | 1609 | 0.460 |
Why?
|
Benzamides | 1 | 2019 | 1379 | 0.450 |
Why?
|
Temperature | 1 | 2019 | 2206 | 0.420 |
Why?
|
Anesthesia | 2 | 2020 | 1561 | 0.410 |
Why?
|
Hospitals, General | 3 | 2023 | 749 | 0.380 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2759 | 0.360 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2569 | 0.340 |
Why?
|
Humans | 43 | 2023 | 744343 | 0.320 |
Why?
|
Fractures, Bone | 1 | 2019 | 1947 | 0.300 |
Why?
|
Hospitalization | 6 | 2023 | 10262 | 0.290 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4838 | 0.280 |
Why?
|
Mental Disorders | 2 | 2023 | 6600 | 0.280 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.260 |
Why?
|
United States | 9 | 2023 | 69872 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.260 |
Why?
|
Telemedicine | 1 | 2022 | 2872 | 0.240 |
Why?
|
Malingering | 1 | 2023 | 77 | 0.220 |
Why?
|
Neuroleptic Malignant Syndrome | 1 | 2023 | 71 | 0.220 |
Why?
|
Adult | 12 | 2023 | 214055 | 0.210 |
Why?
|
Lupus Vasculitis, Central Nervous System | 1 | 2022 | 33 | 0.210 |
Why?
|
Hospitals, Psychiatric | 1 | 2023 | 332 | 0.200 |
Why?
|
Thiopental | 1 | 2021 | 59 | 0.200 |
Why?
|
Molecular Conformation | 2 | 2020 | 563 | 0.190 |
Why?
|
Vermont | 1 | 2020 | 85 | 0.190 |
Why?
|
Fragile X Syndrome | 1 | 2022 | 115 | 0.190 |
Why?
|
Pandemics | 2 | 2020 | 8388 | 0.190 |
Why?
|
Illinois | 1 | 2020 | 119 | 0.190 |
Why?
|
Hydrogen Bonding | 2 | 2019 | 293 | 0.190 |
Why?
|
Peptidomimetics | 1 | 2020 | 34 | 0.190 |
Why?
|
Maintenance | 1 | 2020 | 25 | 0.190 |
Why?
|
Peptides | 3 | 2020 | 4409 | 0.190 |
Why?
|
Adolescent Psychiatry | 1 | 2021 | 148 | 0.180 |
Why?
|
Adolescent | 6 | 2023 | 85781 | 0.180 |
Why?
|
Neuromuscular Depolarizing Agents | 1 | 2019 | 45 | 0.180 |
Why?
|
Patient Discharge | 2 | 2023 | 3313 | 0.180 |
Why?
|
Alkynes | 1 | 2020 | 306 | 0.180 |
Why?
|
Succinylcholine | 1 | 2019 | 67 | 0.180 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2020 | 87 | 0.170 |
Why?
|
Comorbidity | 3 | 2022 | 10388 | 0.170 |
Why?
|
bcl-2-Associated X Protein | 2 | 2017 | 295 | 0.170 |
Why?
|
Small Molecule Libraries | 2 | 2016 | 720 | 0.160 |
Why?
|
Hospitals | 2 | 2023 | 3952 | 0.160 |
Why?
|
Disulfides | 1 | 2020 | 457 | 0.160 |
Why?
|
Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2018 | 52 | 0.160 |
Why?
|
Anesthetics, Intravenous | 1 | 2021 | 417 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2020 | 1434 | 0.160 |
Why?
|
Phenyl Ethers | 1 | 2017 | 58 | 0.150 |
Why?
|
Dopamine Agonists | 1 | 2020 | 355 | 0.150 |
Why?
|
Hysterectomy | 1 | 2023 | 927 | 0.150 |
Why?
|
Palmitic Acid | 1 | 2018 | 154 | 0.150 |
Why?
|
Forearm | 1 | 2019 | 409 | 0.150 |
Why?
|
California | 1 | 2020 | 1402 | 0.140 |
Why?
|
Electroencephalography | 2 | 2021 | 6150 | 0.140 |
Why?
|
Benzodiazepines | 1 | 2022 | 1101 | 0.140 |
Why?
|
Cohort Studies | 3 | 2023 | 40561 | 0.130 |
Why?
|
Male | 10 | 2023 | 350118 | 0.130 |
Why?
|
SOS1 Protein | 1 | 2015 | 41 | 0.130 |
Why?
|
Hydrocarbons | 1 | 2015 | 106 | 0.130 |
Why?
|
Allosteric Regulation | 1 | 2016 | 408 | 0.120 |
Why?
|
Apoptosis | 4 | 2020 | 9727 | 0.120 |
Why?
|
Depression | 3 | 2023 | 7766 | 0.110 |
Why?
|
Female | 8 | 2023 | 380194 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 2 | 2015 | 4554 | 0.110 |
Why?
|
src Homology Domains | 1 | 2012 | 364 | 0.100 |
Why?
|
Aged | 5 | 2021 | 163280 | 0.100 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2021 | 6038 | 0.100 |
Why?
|
Psychiatry | 1 | 2023 | 1695 | 0.100 |
Why?
|
Middle Aged | 5 | 2023 | 213383 | 0.090 |
Why?
|
Child | 3 | 2023 | 77709 | 0.090 |
Why?
|
Time Factors | 2 | 2023 | 40075 | 0.090 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2015 | 1213 | 0.090 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1157 | 0.090 |
Why?
|
Length of Stay | 1 | 2023 | 6309 | 0.090 |
Why?
|
ras Proteins | 1 | 2015 | 1060 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1889 | 0.090 |
Why?
|
Protein Structure, Secondary | 3 | 2018 | 1246 | 0.080 |
Why?
|
Massachusetts | 1 | 2021 | 8663 | 0.080 |
Why?
|
Logistic Models | 1 | 2023 | 13408 | 0.080 |
Why?
|
Mesencephalon | 1 | 2009 | 329 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1526 | 0.080 |
Why?
|
Prospective Studies | 2 | 2022 | 53288 | 0.070 |
Why?
|
Antipsychotic Agents | 1 | 2020 | 3057 | 0.070 |
Why?
|
Young Adult | 2 | 2022 | 56430 | 0.070 |
Why?
|
Drosophila Proteins | 1 | 2015 | 1703 | 0.070 |
Why?
|
Glutamic Acid | 1 | 2009 | 1169 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18370 | 0.060 |
Why?
|
Models, Molecular | 3 | 2020 | 5456 | 0.050 |
Why?
|
Body Mass Index | 1 | 2020 | 12720 | 0.050 |
Why?
|
Prognosis | 1 | 2023 | 29063 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7181 | 0.050 |
Why?
|
Dopamine | 1 | 2009 | 1591 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2916 | 0.050 |
Why?
|
Axons | 1 | 2009 | 1684 | 0.050 |
Why?
|
GABA Modulators | 1 | 2020 | 107 | 0.040 |
Why?
|
Obesity | 1 | 2022 | 12745 | 0.040 |
Why?
|
Protein Binding | 3 | 2017 | 9386 | 0.040 |
Why?
|
Lorazepam | 1 | 2020 | 145 | 0.040 |
Why?
|
Central Nervous System Depressants | 1 | 2020 | 167 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2020 | 298 | 0.040 |
Why?
|
Hemolysis | 1 | 2020 | 420 | 0.040 |
Why?
|
Lipid Bilayers | 1 | 2020 | 381 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7880 | 0.040 |
Why?
|
Tryptophan | 1 | 2020 | 478 | 0.040 |
Why?
|
Cell Line | 3 | 2018 | 15997 | 0.040 |
Why?
|
Liposomes | 1 | 2020 | 759 | 0.040 |
Why?
|
Documentation | 1 | 2022 | 871 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10943 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2017 | 3760 | 0.030 |
Why?
|
Molecular Structure | 1 | 2020 | 1899 | 0.030 |
Why?
|
Risk Factors | 1 | 2022 | 72290 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2020 | 1877 | 0.030 |
Why?
|
Melatonin | 1 | 2020 | 721 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 3129 | 0.030 |
Why?
|
Chromatography, Gel | 1 | 2015 | 668 | 0.030 |
Why?
|
Rabbits | 1 | 2020 | 4894 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2016 | 413 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2187 | 0.030 |
Why?
|
Fluorescence | 1 | 2015 | 751 | 0.030 |
Why?
|
Mutagenesis | 1 | 2016 | 1266 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2012 | 459 | 0.030 |
Why?
|
Erythrocytes | 1 | 2020 | 2455 | 0.020 |
Why?
|
Point Mutation | 1 | 2016 | 1623 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2023 | 3528 | 0.020 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2009 | 70 | 0.020 |
Why?
|
Animals | 6 | 2020 | 168757 | 0.020 |
Why?
|
Receptors, Kainic Acid | 1 | 2009 | 88 | 0.020 |
Why?
|
Bacteria | 1 | 2020 | 2114 | 0.020 |
Why?
|
Kainic Acid | 1 | 2009 | 199 | 0.020 |
Why?
|
Microfluidics | 1 | 2015 | 662 | 0.020 |
Why?
|
Growth Cones | 1 | 2009 | 117 | 0.020 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 2009 | 176 | 0.020 |
Why?
|
Intracellular Space | 1 | 2009 | 212 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2009 | 494 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3846 | 0.020 |
Why?
|
Protein Conformation | 1 | 2016 | 4011 | 0.020 |
Why?
|
Calcium Channels, L-Type | 1 | 2009 | 240 | 0.020 |
Why?
|
Mice | 4 | 2018 | 81183 | 0.020 |
Why?
|
Receptors, AMPA | 1 | 2009 | 331 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1692 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5179 | 0.020 |
Why?
|
Primary Health Care | 1 | 2023 | 4558 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2219 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2015 | 1708 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2009 | 1472 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2009 | 895 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 13815 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7279 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14557 | 0.010 |
Why?
|
Escherichia coli | 1 | 2015 | 4217 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 18111 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16689 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9734 | 0.010 |
Why?
|
Calcium | 1 | 2009 | 5756 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 19229 | 0.010 |
Why?
|
Mutation | 1 | 2015 | 29786 | 0.010 |
Why?
|
Neoplasms | 1 | 2016 | 21683 | 0.000 |
Why?
|